Connecticut Innovations

[Connecticut Innovations](http://www.ctinnovations.com) provides strategic capital and operational insight to to companies in high-tech industries such as energy, biotechnology, information technology, and photonics. Their mission is to be the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. By offering flexible financing, strategic guidance and introductions to valuable partners, Connecticut innovations enable promising businesses to thrive.

David M. Audibert

MD of Investments

Matthew A. Bloom

Director, Investments

Lauren Carmody

VP of Marketing and Communications

Margaret Cartiera

VP and Fund Manager

Joseph J. Casparino

MD of Information Technology

Jeremy Crisp

EVP and Chief Innovation Officer

Kevin Crowley

Senior MD, Investments

Tamyra Davis

Senior Associate

Cyndi Green

MD

Robert A. Kennedy

Director

Barbara Lesh

Program Associate of Small Business Innovations

Peter Longo

Senior MD, Investments

Alison Malloy

Director, Investments

Matthew J. McCooe

CEO

Ted Murphy

SVP, Venture Lending

Pauline Murphy

Senior MD, Investments

Patrick O'Neill

MD, Investments

Matt Panicali

Associate, Investments

Antonio Roberto

MD, Strategic Investments

Douglas J. Roth

MD, Investments

Philip Siuta

COO and CFO

Matthew D. Storeygard

MD, Investments

Daniel Wagner

Senior MD, Investments

Linda Wieleba

SVP and Senior Loan Officer

David Wurzer

EVP and CIO

Wenping Zhou

Bioscience Investment Associate

340 past transactions

iDevices

Venture Round in 2014
iDevices is an American based company that creates and specializes in unique products using our extensive knowledge of wireless connectivity. In 2010 iDevices successfully developed and launched the iGrill and iGrill applications. The company is currently in the development of a variety of new products. iDevices operates a successful consulting practice, helping companies App enable and wirelessly connect their existing and future products to Apple and Android devices. Their product development and consulting departments work hand and hand in order to share the knowledge and experience on both sides of their business.

Torigen Pharmaceuticals

Series A in 2019
Torigen Pharmaceuticals is a company focused on being at the forefront of immuno-oncology innovation. They strive to bring novel approaches to the market to tackle companion animal cancers, building on years of existing scientific research and pushing the boundaries of innovation.

FMP Products

Venture Round in 2010
FMP Products develops and sells laboratory automation equipment.

Perosphere

Debt Financing in 2014
Perosphere also identifies market opportunities where application of drug delivery technology to an already marketed drug can create a new patent-protected medical use or enhance safety, efficacy or ease of use. Perosphere recognizes the scientific and marketing opportunities afforded by its drug candidates and pursues clinical development using the U.S. FDA's 505(b)(2) regulatory pathway whenever possible. The 505(b)(2) pathway enables the expedited development of drug candidates that are based on drugs already demonstrated to be safe and effective. Perosphere's proprietary drug delivery technology is protected by over 30 issued and 10 pending patents.

Pattern Genomics

Seed Round in 2013
Pattern Genomics, LLC develops Daydreamer, a software platform that enables simultaneous pattern analysis of DNA sequences and molecular assay design based on large-scale DNA sequencing data. It also provides a service that leverages DNA sequencing and bioinformatics to prototype complex assays focusing on infectious disease. In addition, the company focuses on offering an assay design service to the diagnostics and pharmaceutical industry, CLIA laboratories, governments, and foundations. Pattern Genomics, LLC is headquartered in Madison, Wisconsin.

Primeter eSecurity

Venture Round in 2007
Primeter eSecurity offers enterprise-level information security, protection, and compliance services.

CircleLink Health

Seed Round in 2013
CircleLink Health offers telephone nursing for chronic care management and behavioral health integration. It allows providers to improve health and earn new medicare payments up to $60K/year per doctor. CircleLink makes it easy by handling patient targeting, enrollment, and integration with various EHRs so doctors can stay on one system. CircleLink uses 100% registered nurses for meaningful remote patient engagement on physicians' behalf.

Vesselon

Pre Seed Round in 2014
Vesselon, Inc. develops and offers therapeutic immuno-oncology complexes that are protected in circulation and actively targeted to tumors. Its platform consists of therapeutic agents in combination with an FDA approved microbubble drug to make the combination work across a spectrum of cancers and other serious diseases. The company also develops a multi-targeted encapsulated oncolytic virus complex to be effective at low titers across a wide range of tumors. Also, the company is developing an encapsulated recombinant interleukin-2 complex targeting clinically relevant dosages to solid tumors with systemic exposure far below that which could cause adverse events. The company was founded in 2012 and is based in Norwalk, Connecticut.

Macton Corporation

Debt Financing in 2014
Macton designs and manufactures large, engineered-to-order, moving structures and equipment for a wide variety of transportation, industrial, architectural and commercial applications. Products include rail maintenance equipment and facility related turntables.

Wellinks

Seed Round in 2014
Wellinks, Inc. offers wearable devices for orthotics and prosthetics. It develops a smart strap that allows doctors, parents, and children to check how long and how tight the brace is being worn for preventing scoliosis surgeries. Wellinks, Inc. was formerly known as 109 Design LLC. The company was incorporated in 2014 and is based in New Haven, Connecticut. As per the transaction announced on January 15, 2020, Wellinks, Inc. operates as a subsidiary of Convexity Scientific Inc.

EyeFree Assisting Communication Ltd.

Private Placement in 2020
EyeFree Assisting Communication Ltd. develops a communication device for patients with locked-in syndrome. Its product includes EyeControl, a wearable personal communication device, which allows patients to communicate using their eye movements. The device is used by the patients with neurological disorders. The company was founded in 2016 and is based in Tel Aviv, Israel.

Forbes Medi-Tech

Series A in 2004
Forbes Medi-Tech Inc. is a life sciences company focused on evidence-based nutritional solutions. A leader in nutraceutical technology, Forbes is a provider of value-added products and cholesterol-lowering ingredients for use in functional foods and dietary supplements. Forbes successfully developed and commercialized its Reducol™ plant sterol blend, which has undergone clinical trials in various matrices and has been shown to lower “LDL” cholesterol levels safely and naturally. Building upon established partnerships with leading retailers and manufacturers across the globe, Forbes helps its customers to develop private label and branded products.

GeneDx

Series B in 2019
Sema4 is a patient-centered predictive health company dedicated to advancing the diagnosis, treatment, and prevention of disease. With their innovative Sema4 Health Intelligence Platform, they’re using advanced network analysis to build better models of human health and deliver personalized insights for patients.

Wellinks

Series B in 2019
Convexity Scientific Inc., a medical technology company, designs and develops medical devices. It offers Flyp, a handheld nebulizer for respiratory diseases. The company was incorporated in 2014 and is headquartered in Fairfield, Connecticut.

Aureus Analytics

Private Placement in 2019
Aureus Analytics Pvt. Ltd. designs and develops CRUX, an artificial Intelligence (AI) based insurance analytics solutions platform designed with cloud-based deployment, natural language generation, and machine learning AI. The company serves the property and casualty and life insurance industries. Aureus Analytics Pvt. Ltd. was founded in 2012 and is headquartered in Singapore and has additional locations in Hartford, United States and Mumbai, India.

eBrevia

Seed Round in 2014
EBrevia is commercializing machine-learning technology developed at Columbia University to analyze, extract information from, and summarize legal documents. The software reduces the time and cost associated with legal document review while improving a user’s accuracy. The technology has applications for due diligence, contract management, and document drafting. EBrevia was one of four national winners in the Startup America DEMO Competition. CIO.com then selected the company as having one of the top ten enterprise products at the DEMO conference. The company also won the Connecticut Technology Council’s Most Promising Software Product of the Year award.

Inbox Health

Seed Round in 2019
Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communication platform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns.

Diameter Health

Private Placement in 2019
Diameter Health transforms patient information into the quantity and quality of interoperable data for healthcare organizations. The core of the Diameter Health platform is Fusion, which enables intelligent data exchange ingestion and cleansing through sophisticated normalization and cleansing processes. Data originating from any certified Electronic Health Record (EHR) is transformed into clinical information optimized for use at the point of care or to be consumed as a rich substrate for analytics.

New Haven Pharmaceuticals

Series A in 2012
New Haven Pharmaceuticals (NHP) is a specialty pharmaceuticals company developing proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications that represent significant market opportunities. The company's novel product pipeline employs proprietary, oral, controlled-release technologies, as well as intellectual property licensed from Yale University, which will enable optimal dosing, safety, efficacy and patient convenience.

LiquiFix

Venture Round in 2010
LiquiFix Inc. manufactures and supplies lubricants, biodegradable degreasers, and cleaners for household and industrial applications. The company’s products are used for various applications, such as kitchens, garages, windows and doors, cars, motorcycles, boats, fishing equipment, sporting equipment, equestrian equipment, skateboards, bicycles, firearms, gyms, schools, hospitals, police and fire stations, offices, manufacturing plants, stores, and hobby areas. It markets and sells its products through stores and online in the United States and internationally. The company was incorporated in 2010 and is based in Stamford, Connecticut.

Azitra

Series B in 2020
Azitra is a clinical-stage medical dermatology company that leverages extensive scientific knowledge about the skin microbiome to discover and develop novel products for the treatment of adverse skin conditions and diseases.The Company’s technology platform, developed in collaboration with scientists at Yale University and the Jackson Laboratory, is based on a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis.

NorthPage

Venture Round in 2013
NorthPage provides a cloud-based digital marketing optimization platform that enables frictionless performance benchmarking, competitive analysis, and best-practice guidance for enterprise marketing organizations. Its solutions enable optimization of Websites, e-commerce sites, mobile marketing, social media, search engine marketing, content marketing, and e-retail programs. The company serves retail, financial services, consumer product, pharmaceutical, and technology companies. NorthPage Inc. was founded in 2007 and is based in Southbury, Connecticut.

Biohaven Pharmaceutical

Venture Round in 2016
Biohaven is a clinical-stage biopharmaceutical company. It has a portfolio of late-stage product candidates targeting neurological diseases, including rare disorders. The company product candidates are based on multiple mechanisms-calcitonin gene-related peptide receptor antagonists, glutamate modulators and myeloperoxidase inhibitor. Its pipeline products include BHV3000-301, BHV3000-302, BHV3000-303, and others.

GestVision

Seed Round in 2014
GestVision, Inc. is commercializing a point of care diagnostic test for preeclampsia. The pregnancy-related condition is often characterized by the symptoms of high blood pressure and protein in the urine. Left untreated, the condition can lead to seizures and even death. Preeclampsia is an equal opportunity problem and is of concern in both developed and developing nations. The US is not immune and sees preeclampsia as a growing problem.

Nest Collaborative

Seed Round in 2022
Nest Collaborative is a provider of on-demand lactation counseling services intended to offer a collection of international board certified lactation consultants who conduct online, video appointments to help guide moms through the breastfeeding process. The company's services are offered via an online platform that offers reimbursed maternal, neonatal and lactation counseling services, enabling women to avail safe, convenient and affordable access to quality pediatric care, at home.

Aventri

Series A in 2010
Aventri offers cloud-based data-driven event management and venue sourcing solutions. Its platform specializes in providing real-time data and analytics on event performance, customer engagement, and increasing measurable events. It was founded in 2008 and is headquartered in Norwalk, Connecticut.

ArcaNatura LLC

Seed Round in 2011
ArcaNatura LLC makes natural and environmentally friendly medical products for pets that are all tested and proven clinically. Founded by three veterinarians, ArcaNatura now brings you new, multifaceted herbal veterinary medicine for dogs, horses and cats that is evidence-based, scientifically founded and clinically proven. Our research has found that our natural solutions are either equally or more effective than other products that contain chemical active ingredients. From production to shipping, we utilize 100% renewable and sustainable ingredients like soothing plant essential oils and naturally anti-bacterial extracts, while also incorporating fair trade sourcing into our production. With herbal veterinary medicine, the quality of the plant extract is critical, so during each step of growing, collecting, extracting and preserving, we meticulously guarantee the safety and efficacy of our ingredients. We believe it's best to treat the root, not the symptom. By tapping into the inexhaustible source of natural solutions found in nature, Arcanatura brings you our very own line of Naturaceuticals to soothe your pet's allergies and ailments.

AxioMx

Venture Round in 2013
AxioMx, founded in 2012 and based in Branford, Connecticut is a leader in recombinant antibody technologies. Its founders, Chris McLeod and Dr. Michael Weiner, are life science entrepreneurs who have previously led successful genomics, next-generation sequencing, microfluidics, bioinformatics and proteomic organizations. AxioMx’s unique platform of proprietary phage display libraries, library screening, and affinity maturation methods provides the technical foundation of the company. The company offers a full range of custom antibody discovery and development services for the research and diagnostic market places.

Combat2Career (C2C, LLC)

Convertible Note in 2011
C2C, LLC DBA Combat2Career® (C2C) is a Connecticut-based technology start-up venture founded in May 2011 by Meghan Brunaugh and Charlotte Creech to assist military members and veterans in the pursuit of higher education and the transition to civilian careers.

Cybrexa, Inc.

Series B in 2019
Cybrexa, Inc. develops DNA repair inhibitors for radio- and chemo-sensitizers in cancer therapeutics. The product consists of peptide-based technology that directly targets tumor microenvironment. Cybrexa, Inc. was formerly known as Cybrexa, Inc. The company was founded in 2016 and is based in New Haven, Connecticut.

Tru Optik

Venture Round in 2019
Tru Optik identity resolution powers the streaming media ecosystem. Tru Optik’s patented Household Graph™ of more than 80 million homes enables the world’s leading brands, agencies, media companies, and platforms to engage consumers across OTT, streaming audio, and gaming with unmatched scale, accuracy and privacy compliance.

CoreChain Technologies

Pre Seed Round in 2021
CoreChain Technologies is a business-to-business payments network built on blockchain technology.

Shizzlr

Seed Round in 2013
Shizzlr is a mobile application development company focused on private group sharing between friends. In August 2011 the company released their first product Shizzlr – a platform agnostic way to create groups around doing things with friends. It was built as a simple way to create everyday casual plans – allowing users to share venues, events, movies, and more into groups to talk about and decide on something to do together. We are releasing our new product in the fall. Groupcentric – a simple and robust group chat API. This allows developers to add private sharing with group chat into their own applications.

Source Defense

Private Placement in 2018
In an industry focused on detection, Source Defense provides websites with the first ever prevention technology for attacks of third-party origin. We are the first ever SAAS platform that allows a site owner to set and enforce permissions, receive real-time alerts and monitor third-party vendors' behavior on their site. By removing the security considerations from third-party integrations, we can save countless man-hours spent on tests and integrations, allowing sites to focus on generating revenues and new opportunities while keeping the site visitors safe and the site in high performance.

futuresTHRIVE

Seed Round in 2021
FuturesTHRIVE develops an AI platform to identify and track pediatric mental health easily. FuturesTHRIVE's platform uses a combination of artificial intelligence, sentiment analysis, and machine learning to provide a mental health baseline that can be used by doctors and families to better understand a child's mental health qualities, thereby helping to identify mental health conditions in children easily and early.

NXT-ID

Seed Round in 2013
NXT-ID provides a comprehensive platform of technology products and services that enable the Internet of Things (IoT). With extensive experience in access control, biometric and behavior-metric identity verification, security and privacy, encryption and data protection, payments, miniaturization and sensor technologies, NXT-ID develops and markets groundbreaking solutions for payment and IoT applications. Its industry-leading technology products and solutions include MobileBio®, a suite of biometric solutions that secure consumers' mobile platforms, the Wocket™, a next-generation smart wallet and the Flye, a digital credit card developed in collaboration with WorldVentures.

CGI Pharmaceuticals

Series C in 2004
Founded out of Yale University, CGI (formerly Cellular Genomics Inc.) began operations in 2000. CGI, in conjunction with several biotech and pharmaceutical partners (Pfizer, Serono, Lilly, Affymetrix, and Schering AG), utilized a unique chemical-genetics approach known as “ASKA” (Analog Sensitive Kinase Alleles) to understand kinase function. CGI Pharmaceuticals is dedicated to the discovery and development of breakthrough small molecule therapeutics for a broad range of oncology and allergy/autoimmune/inflammatory disease (AAID) indications. The Company’s fully integrated drug discovery infrastructure comprises proprietary kinase biology and chemistry, extensive lead generation and optimization capabilities, as well as drug metabolism/pharmacokinetics (DMPK) expertise. Utilizing its comprehensive chemistry capabilities, CGI has generated a proprietary small molecule kinase inhibitor library of over 50,000 compounds (all compounds designed and synthesized by CGI). To date, CGI has been awarded 8 U.S. patents covering its novel collection of kinase inhibitors. Moreover, all three of CGI’s drug discovery and development programs are based on hits obtained from CGI’s library.

IvyTech Design LLC

Seed Round in 2020
Our patent-pending technology would give the surgeon better access to joint and fracture surfaces during distraction as well as more accurate alignment during compression, which could reduce the risk of complications due to improper bone fusion. Our devices were tailored for specific orthopedic applications, including correction of diaphyseal nonunion in long bones, reduction of transverse fractures in foot and hand, and anterior cervical discectomy and fusion in the spine.

Logicbroker

Series A in 2013
Logicbroker Inc., logicbroker enables Retailers, Suppliers, and Logistics Providers of all sizes to leverage the latest in electronic data exchange technology. By building a powerful system that is flexible enough to work with both proprietary and standard industry platforms, logicbroker is the right application to move your business to the next level.

Intus Bio

Venture Round in 2018
Shoreline Biome is a developer of microbiome technologies and products created to identify and quantify the bacteria in the human microbiome. The company's products feature comprehensive lysis of even hard to crack microbes, simple workflow, and the ability to identify organisms down to the strain-level and can also be used on the Illumina and PacBio sequencing platforms,enabling clients with easy-to-use, cost-effective tools and reagents to support end-to-end microbiome analysis.

Keisense

Seed Round in 2007
Keisense Limited offers technologies and systems that allow users to enter words and sentences in electronic devices. It offers PriText, a technology for text input mechanisms in mobile devices, smartphones, cellphones, PDAs, email devices, and television remote controls. The company has operations in the United States. Keisense Limited is based in Welwyn Garden City, the United Kingdom.

FallCall Solutions, LLC

Private Placement in 2018
Mission: FallCall Solutions, LLC will become the premier innovator in simplified communication solutions for the elder population and their caregivers. Through these telemonitoring solutions, we aim to maximize elder independence and caregiver peace of mind. By creating them on mobile platforms already widely adopted, our focus is on building software based solely on the needs of the consumer rather than the trying to create and introduce new ecosystems into our customers’ lives. Vision: To make telemonitoring a seamless part of our lives: ready to help us when we need it the most, and invisible when we don’t.

CYA Technologies

Series B in 2007
CYA Technologies, Inc. offers data recovery solutions. Its products include CYA SmartRecovery, which enables synchronized backups and granular recovery of the enterprise content management system information, and helps addressing issues associated with P8 repository corruptions; CYA SmartReplicator that offers the asynchronous replication of information; and CYA Connector, which manages recovered data sets on secondary storage devices. The company also offers data integrity management, and discrete content back up and recovery services. It serves aerospace, financial services, government, high technology, life sciences, and manufacturing markets. The company was founded in 1998 and is based in Shelton, Connecticut with an additional office in West Sussex, the United Kingdom. As of January 1, 2009, CYA Technologies, Inc. operates as a subsidiary of enChoice, Inc.

Budderfly

Venture Round in 2019
Budderfly is disrupting the energy industry by leading the digital transformation of energy consumption through its unique Energy-as-a-Service model. With no cost to its clients, Budderfly implements proprietary energy intelligence software, energy efficient technology upgrades that span more than 25 savings categories, and IoT devices that meter, control, and optimize energy usage at the point of consumption within each facility across the enterprise. Budderfly’s ongoing services and proactive maintenance ensure that a building’s energy infrastructure never becomes outdated. The result is significant, immediate and progressive energy expense savings, upgraded facilities, and a reduced carbon footprint for its client facilities.

IsoPlexis

Series C in 2019
IsoPlexis is a life science technology company developing a single-cell detection system that identifies a wide range of patient immune responses at the single-cell level. Its platform can assess the safety and efficacy of therapeutics and monitor disease progression, enabling improved therapeutic development, and informing physician decisions. The company was founded in 2013 and is headquartered in Branford, Connecticut.

Cytosolix

Convertible Note in 2019
Cytosolix develops novel oral and IV derivatives that target tumor acidity to improve the efficacy of small molecule cancer therapeutics. Cytosolix's Tumor Activated Permeability System, produces weakly-acidic derivatives of known oncology drugs, that enhance the uptake by cancer cells while restricting the uptake by healthy cells, enabling physicians to get safer and more effective therapy for drugs with dose-limiting toxicities.

eBrevia

Seed Round in 2013
EBrevia is commercializing machine-learning technology developed at Columbia University to analyze, extract information from, and summarize legal documents. The software reduces the time and cost associated with legal document review while improving a user’s accuracy. The technology has applications for due diligence, contract management, and document drafting. EBrevia was one of four national winners in the Startup America DEMO Competition. CIO.com then selected the company as having one of the top ten enterprise products at the DEMO conference. The company also won the Connecticut Technology Council’s Most Promising Software Product of the Year award.

SAMI Health

Venture Round in 2012
SAMI Health, Inc. is a privately owned clinical health informatics company headquartered in Westport, CT. The organization was founded following a personal medical tragedy that led to a purposed mission to address the fundamental issues in HIT.

Skystream Markets

Series A in 2014
Skystream Markets Inc. operates as an institutional transaction platform for the environmental markets in the United States and internationally. Its platform offers automation in the trade cycle, including execution, trade capture, processing, and reporting. The company also acts as a neutral intermediary for market participants in the environmental markets; provides client support, which includes structuring customized physical and financial hedging strategies in the spot, option, and forward markets; and builds auctions and electronic markets for the primary and secondary markets in renewable energy certificate (REC) markets. In addition, Skystream Markets offers transaction services in REC markets. Further, the company operates a trading platform that connects pools of capital with renewable power projects through an electronic process. It serves power producers and major trading counterparties. Skystream Markets was founded in 2009 and is based in New York, New York with a sales office in Boston, Massachusetts.

AxioMx

Venture Round in 2012
AxioMx, founded in 2012 and based in Branford, Connecticut is a leader in recombinant antibody technologies. Its founders, Chris McLeod and Dr. Michael Weiner, are life science entrepreneurs who have previously led successful genomics, next-generation sequencing, microfluidics, bioinformatics and proteomic organizations. AxioMx’s unique platform of proprietary phage display libraries, library screening, and affinity maturation methods provides the technical foundation of the company. The company offers a full range of custom antibody discovery and development services for the research and diagnostic market places.

Payveris

Private Placement in 2019
Payveris is the creator of The MoveMoney Platform, an Open API cloud-based platform that enables FIs to control, simplify + extend digital money movement capabilities to any application or device while lowering user experience friction, significantly reducing operating costs + future-proofing the IT investment. Shift from a product-centric digital payments model to a platform-centric model today!

Ancera

Seed Round in 2013
Ancera, Inc. develops and manufactures pathogen detection equipment for high speed sorting, separation, and concentration of cells from fluid samples. The company was incorporated in 2011 and is based in Branford, Connecticut.

Mindnest Health

Seed Round in 2020
MindNest Health, Inc. develops a digital parent training system platform that enables parents to use the same clinically validated behavior interventions with their kids that are used by experts at academic centers. It offers programs for ADHD, autism, and tantrums. It also developing training modules for anxiety and substance abuse. The company was founded in 2016 and is based in New Haven, Connecticut.
Covr Financial Technologies, Inc. operates as a digitally enabled brokerage general agency (BGA) that provides life, long-term care, and disability insurances for financial institutions, their advisors, and their customers. It offers Covr Advisor digital platform for financial advisors to meet their clients’ life insurance needs that allows the advisors to select the needed product, including life, long-term care, or disability coverage. The company also provides Covr Consumer digital platform for banks and credit unions to sell life insurance online. In addition, it offers Covr Insights to manage, track, and analyze existing in-force life insurance policies. The company was founded in 2013 and is based in Boise, Idaho.

FallCall Solutions, LLC

Seed Round in 2018
Mission: FallCall Solutions, LLC will become the premier innovator in simplified communication solutions for the elder population and their caregivers. Through these telemonitoring solutions, we aim to maximize elder independence and caregiver peace of mind. By creating them on mobile platforms already widely adopted, our focus is on building software based solely on the needs of the consumer rather than the trying to create and introduce new ecosystems into our customers’ lives. Vision: To make telemonitoring a seamless part of our lives: ready to help us when we need it the most, and invisible when we don’t.

Biorez

Private Placement in 2018
Biorez, Inc. is a early-stage regenerative medicine company engaged in developing bioresorbable scaffold implants to regenerate functional tissue in vivo. Its lead product candidate is an off-the-shelf implant for ACL reconstruction that spares harvesting of patient donor-tissue, and provides a better alternative to cadaver-based materials. The company plans to commercialize its lead ACL technology, as well as expand its platform to develop new and innovative clinical solutions.

Intus Bio

Private Placement in 2018
Shoreline Biome is a developer of microbiome technologies and products created to identify and quantify the bacteria in the human microbiome. The company's products feature comprehensive lysis of even hard to crack microbes, simple workflow, and the ability to identify organisms down to the strain-level and can also be used on the Illumina and PacBio sequencing platforms,enabling clients with easy-to-use, cost-effective tools and reagents to support end-to-end microbiome analysis.

Torigen Pharmaceuticals, Inc.

Private Placement in 2019
Torigen Pharmaceuticals, Inc. develops veterinary cancer treatment solutions for animals. The company offers personalized cancer immunotherapies to the veterinary market. It serves veterinarians and pet owners. The company was founded in 2013 and is based in Farmington, Connecticut.

Source Defense

Series A in 2018
In an industry focused on detection, Source Defense provides websites with the first ever prevention technology for attacks of third-party origin. We are the first ever SAAS platform that allows a site owner to set and enforce permissions, receive real-time alerts and monitor third-party vendors' behavior on their site. By removing the security considerations from third-party integrations, we can save countless man-hours spent on tests and integrations, allowing sites to focus on generating revenues and new opportunities while keeping the site visitors safe and the site in high performance.

deets, inc.

Series A in 2012
deets Inc., is a Westport, Connecticut-based mobile technology company dedicated to improving people’s lives and productivity through meaningful, on-the-go sharing and collaboration solutions. Founded in 2011 by the former leadership of successful online companies including Priceline and Hotwire, deets launched its first product in 2012. Its Mobile and Web communication software dynamically synchronizes contacts and lets users manage group conversations and collaboration all from a single mobile dashboard. For more information on deets, please visit www.sharedeets.com.
Bristol-Myers Squibb Company, through its subsidiaries, engages in the discovery, development, licensing, manufacturing, marketing, distribution and sale of pharmaceuticals and nutritional products. The company operates in two segments, Pharmaceuticals and Nutritionals. - The Nutritionals segment is operated through the company's subsidiary Mead Johnson Nutrition Company (Mead Johnson). - The Pharmaceuticals segment is made up of the global pharmaceutical and international consumer medicines business.

NourishedRx

Seed Round in 2022
NourishedRx is a provider of personalized food solutions for a health plan and providers' most vulnerable members such as those facing diet-sensitive chronic health conditions and who are often at risk of nutrition insecurity. The company also offers education and encouragement to individuals to create lasting behavior change. Their custom solutions deliver increased member engagement and satisfaction, improved clinical outcomes, and meaningful cost savings. It was founded in 2019 in Stamford, Connecticut.

Tru Optik

Private Placement in 2019
Tru Optik identity resolution powers the streaming media ecosystem. Tru Optik’s patented Household Graph™ of more than 80 million homes enables the world’s leading brands, agencies, media companies, and platforms to engage consumers across OTT, streaming audio, and gaming with unmatched scale, accuracy and privacy compliance.

Helix Therapeutics

Series A in 2010
Helix Therapeutics, Inc. develops deoxyribonucleic acid (DNA) based therapeutics. It develops novel sequence-specific gene-targeting reagents for the treatment of HIV/AIDS and common genetic diseases, such as sickle cell anemia, thalassemia, and cystic fibrosis.

Avitus Orthopaedics

Seed Round in 2014
Avitus Orthopaedics, Inc., a medical device company, develops and commercializes minimally invasive orthopedic surgical devices for autologous bone graft harvesting. It offers Avitus bone harvester, a device to harvest cancellous bone and marrow. Avitus Orthopaedics, Inc. was formerly known as BOSS Medical, Inc. and changed its name to Avitus Orthopaedics, Inc. in March 2014. The company was founded in 2011 and is headquartered in Shelton, Connecticut.

Silversky

Venture Round in 2000
As companies struggle with the increasing security requirements placed on their information-intensive businesses, SilverSky’s cloud-based security solutions simultaneously reduce cost, manage complexity and master all compliance requirements from a single powerful platform. Guided by a mission to simplify how customers secure their most important information, SilverSky creates solutions that enable clients pursue business ambitions without having to worry about security. Operated by leading thinkers in the security industry, SilverSky has realized the promise of cloud security solutions – simple, manageable, cost effective. For years, SilverSky has been recognized as a leading managed services provider of business email and network security services. They have hosted, secured and monitored the information assets of thousands of large enterprises and highly regulated businesses using their proprietary security software. As one of the industry’s most trusted managed services provider, SilverSky has built solutions that satisfy the world’s most demanding regulators and auditors.

Simcha Therapeutics

Series A in 2020
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer. The company uses directed evolution to engineer novel cytokines designed to unlock the precision and power of the immune system. Simcha’s lead program, ST-067, is a designer IL-18 cytokine that has shown potent antitumor effects in animal models, both as a monotherapy and when combined with anti-PD-1 checkpoint inhibitors, as described in Nature in June 2020. It was founded in 2018 and is headquartered in New Haven, Connecticut, USA.

Emme E2MS

Series A in 2012
Emme E2MS, LLC provides energy management solutions for the light commercial and residential markets. The company offers Energy and Environmental Management System, a platform that provides environmental controls and detailed energy monitoring solutions; and +Energy that displays electricity consumption in kilowatt/hours, dollars, and by carbon footprint. It also provides SmartSensors, heating and cooling monitor systems, wireless outdoor temperature sensors, and wireless receivers. The company was incorporated in 2012 and is based in Beaverton, Oregon.

SecBI

Series A in 2016
SecBI gives security analysts the intelligence they need to investigate and respond faster. We’re putting the latest advances in machine learning to work – refining, contextualizing and prioritizing the most valuable information from all of your SIEM and log data so that everything you need is at your fingertips. Then, based on our data analysis and your investigation, we provide highly targeted remediation recommendations that show you exactly what traffic will be blocked and how it will impact your users.

Nest Collaborative

Seed Round in 2021
Nest Collaborative is a provider of on-demand lactation counseling services intended to offer a collection of international board certified lactation consultants who conduct online, video appointments to help guide moms through the breastfeeding process. The company's services are offered via an online platform that offers reimbursed maternal, neonatal and lactation counseling services, enabling women to avail safe, convenient and affordable access to quality pediatric care, at home.

Enko Chem

Venture Round in 2021
Enko Chem discovers and develops novel products for farmers to protect their crops from pests and diseases. Their proprietary technology platform represents a revolutionary approach to rapidly discover safe and economical solutions that are needed to ensure sustainable food production. It was founded in 2017 and headquartered in Woburn, Massachusetts.

Phlatbed

Venture Round in 2018
Phlatbed Inc. develops an application for consumer logistics. The product can be used to connect with local drivers who register with the company to move stuff from one place to another. The request can be placed real time and customers can choose from multiple drivers. Phlatbed Inc. was founded in 2016 and is based in Norwalk, Connecticut.

IntelliBoard

Private Placement in 2020
IntelliBoard provides analytic and reporting services to education communities and institutions that want expanded reporting and analytics for their LMS platform. We help extract the statistical data gathered within the LMS and present it on a single dashboard in the form of printable charts, graphs, and analytics.

Inbox Health

Series A in 2021
Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communication platform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns.

Davra

Grant in 2017
Davras' IoT Platform provides organizations with a flexible, secure and integrated platform to fully leverage current and future IoT deployments. Davra IOT platform is the only available IoT Platform on AWS SaaS Contracts (https://aws.amazon.com/marketplace/saas) giving it a very strong GTM strategy ahead of other IoT platform vendors trying to attract System Integrator Partners. Davras' vision is to provide a complete Horizontal IoT AEP platform that allows our customers to define, build and bring to market vertical specific IoT applications. Davra Leads with Transportation Vertical The ConnecThing™ IoT AEP platform is public cloud, private cloud (Openstack) based, simple to use application enablement platform that takes critical data from the network and any connected devices or sensors and publishes it through our IOT open API making it easy to build and run Internet of Things (IoT) applications.

DiA Imaging Analysis

Series A in 2018
DiA Imaging Analysis provides advanced AI-based ultrasound analysis smarter and accessible. It solves the two main challenges clinicians face when using ultrasound: acquiring the right image and automatically analyzing it, to find clinical abnormalities that today they are struggling to find visually. DiA's automated tools can be easily be added into any ultrasound device or healthcare IT system, just like an App. The company holds FDA/CE Clearances for its cardiac toolbox, generating revenues and having thousands of users around the world.

Shelf

Series A in 2020
The workplace has changed. Teams now live in different parts of the country and, possibly, even the world. Collaborating across projects and continents is becoming the new norm. Distributed teams live and die by their ability to quickly learn, share key knowledge and take the right action at the right time. But there is a problem. Currently stuff is scattered and disorganized all over the place and the products meant to solve this content sprawl, like SharePoint and Confluence, are expensive, difficult to use and hard to search. In building a solution the Shelf team went beyond software and set out to understand the Science of Organization. They consulted Harvard librarians, change management experts, and information architects. With the help of these global thought leaders, knowledge management best practices were built into the core of the product. Shelf is designed to help declutter and organize your most important content. Everything about Shelf, from our search to our customer support, reflects the passion and drive of our team to build a better way to harness knowledge and make things easy to find and share. People use Shelf to find the information they need to publish a story, make a pitch, or close an important deal, without the pain of redoing work or wasting time tracking things down. Its Shelf’s mission to help millions of distributed teams throughout the globe accelerate their ability to learn, share and succeed. We are reimagining the library for the workplace of tomorrow and won’t stop until we’ve integrated all the important places where important content is buried. Shelf is the missing link in a rapidly evolving, distributed workplace.

iCleanse

Seed Round in 2013
ReadyDock, Inc. manufactures multi-bay docking stations for secure storage, charging, and disinfection of mobile devices. It offers ReadyDock Duo Disinfection Station, a thin profile with a wide-tray capable of processing multiple large and small footprint mobile devices; and solutions for C5/F5 series tablets. The company’s products are used to support workflow and the overall management of mobile devices in hospitals, education, retail, food service, and other applications that require charging, storage, and security of these devices. It offers its products through resellers. The company was founded in 2012 and is based in Avon, Connecticut. ReadyDock, Inc. operates as a subsidiary of Advanced Technical Support, Inc.

1906

Venture Round in 2022
1906, one of the most innovative brands in cannabis edibles, creates groundbreaking functional formulations of cannabis and plant medicines. 1906's lineup delivers six unique experiences that promote sleep, energy, arousal, relaxation, cognitive focus and a happy mood, all in consistently fast-acting formulations using single-strain organic cannabis. 1906 supports medicinal cannabis research and invests a percentage of its revenue in clinical trials and educating healthcare practitioners. The company also invests in corporate social responsibility, specifically targeting employment opportunities for those formerly incarcerated individuals who have paid the heaviest price for a century of cannabis prohibition.

Biorez

Series C in 2018
Biorez, Inc. is a early-stage regenerative medicine company engaged in developing bioresorbable scaffold implants to regenerate functional tissue in vivo. Its lead product candidate is an off-the-shelf implant for ACL reconstruction that spares harvesting of patient donor-tissue, and provides a better alternative to cadaver-based materials. The company plans to commercialize its lead ACL technology, as well as expand its platform to develop new and innovative clinical solutions.

Biorez

Venture Round in 2014
Biorez, Inc. is a early-stage regenerative medicine company engaged in developing bioresorbable scaffold implants to regenerate functional tissue in vivo. Its lead product candidate is an off-the-shelf implant for ACL reconstruction that spares harvesting of patient donor-tissue, and provides a better alternative to cadaver-based materials. The company plans to commercialize its lead ACL technology, as well as expand its platform to develop new and innovative clinical solutions.

Rapid Oxygen Company

Venture Round in 2016
Rapid Oxygen Company, LLC develops, manufactures, and distributes a portable emergency oxygen system that delivers oxygen in various emergency applications. It offers R15, a non-explosive emergency oxygen unit for use in airports, homes, casinos, day care facilities, disaster relief, drug overdose situations, first aid, fitness centers, golf and country clubs, hotels and resorts, manufacturing locations, offices, pharmaceutical companies, public spaces, and schools. The company was incorporated in 2013 and is based in Stamford, Connecticut.
SRS partners with state and local governments to administer C-PACE programs via its proprietary tech platform, PACEworx.

OncoSynergy

Series A in 2018
The vision of OncoSynergy, a UCSF spin-out, is to radically improve outcomes for patients with unmet needs in oncology with Resistance Mechanism Inhibitors (RMIs). This new class of therapeutics simultaneously targets multiple hallmarks of cancer progression and have demonstrated dramatic preclinical efficacy as monotherapy and in strategic combinations. It was founded in 2011 and is headquartered in Greenwich, Connecticut.

REMOTV

Seed Round in 2007
REMOTV is a flexible and efficient platform for streaming media on the internet. REMOTV has created the first platform that can stream any type of media, in any codec, to any internet connected device. Users can download install channels, point them to the directories where they store media, and the content is instantly available to them from any internet connected device. Users can add friends and access shared content, share their own content, or make publicly available content.

eBrevia

Convertible Note in 2012
EBrevia is commercializing machine-learning technology developed at Columbia University to analyze, extract information from, and summarize legal documents. The software reduces the time and cost associated with legal document review while improving a user’s accuracy. The technology has applications for due diligence, contract management, and document drafting. EBrevia was one of four national winners in the Startup America DEMO Competition. CIO.com then selected the company as having one of the top ten enterprise products at the DEMO conference. The company also won the Connecticut Technology Council’s Most Promising Software Product of the Year award.

Eli Nutrition

Seed Round in 2014
Eli Nutrition, Inc. develops antacid products. It offers Tummyzen, an antacid pill that offers heartburn relief. The company was incorporated in 2013 and is based in New Haven, Connecticut.

Vacayo

Seed Round in 2018
Vacayo is a real estate management and service platform that helps owners rent their properties seamlessly and with higher income, leveraging Superhosts for on-the-ground operations. Despite the growth of the sharing economy, homeowners monetize less than 2 million of the 8 million second homes in the US. We leverage technology & big data to higher profits, total coverage, and better options owners. Vacayo allows owners to put their vacation rental on autopilot. Our system is cutting the typical costs of property management companies by 30%-60%.

eBrevia

Seed Round in 2013
EBrevia is commercializing machine-learning technology developed at Columbia University to analyze, extract information from, and summarize legal documents. The software reduces the time and cost associated with legal document review while improving a user’s accuracy. The technology has applications for due diligence, contract management, and document drafting. EBrevia was one of four national winners in the Startup America DEMO Competition. CIO.com then selected the company as having one of the top ten enterprise products at the DEMO conference. The company also won the Connecticut Technology Council’s Most Promising Software Product of the Year award.

Trinity Mobile Networks

Venture Round in 2017
Trinity Mobile Networks seeks to improve data speed and total network bandwidth for mobile networks. The company develops wireless mesh networking technologies to provide affordable connectivity for its users. Trinity Mobile Networks has developed a new network architecture that improves the performance of mesh networks and an accompanying android application which makes use of its platform. This application allows android devices to receive data through high-quality, inexpensive mesh connections and reduce their reliance on expensive cellular services.

AlloMek Therapeutics

Private Placement in 2016
AlloMek Therapeutics LLC, a pharmaceutical company, discovers and develops targeted therapies for cancer patients. The company offers MEK kinase inhibitors that improve the biopharmaceutical properties of previous MEK inhibitors. It provides -1374, an allosteric MEK kinase inhibitor that combines potent activity against MEK1/2 kinase and against chemo-resistant ovarian cancer stem cells. AlloMek Therapeutics LLC was formerly known as AlloStem Therapeutics, LLC. The company was founded in 2010 and is based in Farmington, Connecticut.

iCleanse

Seed Round in 2013
ReadyDock, Inc. manufactures multi-bay docking stations for secure storage, charging, and disinfection of mobile devices. It offers ReadyDock Duo Disinfection Station, a thin profile with a wide-tray capable of processing multiple large and small footprint mobile devices; and solutions for C5/F5 series tablets. The company’s products are used to support workflow and the overall management of mobile devices in hospitals, education, retail, food service, and other applications that require charging, storage, and security of these devices. It offers its products through resellers. The company was founded in 2012 and is based in Avon, Connecticut. ReadyDock, Inc. operates as a subsidiary of Advanced Technical Support, Inc.

PCC Technology Group

Venture Round in 2014
PCC Technology Group, LLC provides business domain expertise and information technology (IT) solutions. It offers application outsourcing solutions, such as application development, application maintenance, application re-platforming, application sun-setting, performance management, quality assurance and testing, and product engineering; project management solutions, including project management framework and project life cycle; and needs assessment deliverables, including joint application design sessions (JAD), published JAD notes, process models, data models, gap analysis matrix, requirements traceability matrix, functional requirements document, technical design document, and prototypes. The company also provides compliance management services, including assessment and planning, online survey, contract and resource management, electronic calendar, on-line vendor reporting, auditing and reconciliation, compliance tracking, compliance reporting, management reporting, ad-hoc reporting, vendor reporting, digital dashboard, performance management, compliance score-card, and drill-down options. In addition, its solutions include content and document management, eGovernance, eSolutions, system integration, strategic planning, and contract professional staffing. Further, the company provides professional services, including management and IT consulting, systems consulting and integration, operations support, and information services outsourcing. It serves health care, public sector, utilities, and manufacturing industries

Affinimark Technologies

Venture Round in 2010
Affinimark Technologies, a private bioscience company based in New Haven, Connecticut, develops proprietary medical diagnostic products addressing market opportunities and serious unmet medical/surgical needs. Its lead product, CerebrostripTM, is a strip-based diagnostic test, derived from Affinimark's own cutting edge research, that will quickly and cost-effectively provide a definitive determination whether a patient has suffered a cerebrospinal fluid leak as a result of surgery or trauma. No such product is currently available, resulting in significant risk to the patient and cost to the healthcare system.

P2 Science

Series A in 2014
P2 Science, Inc., a bio-renewable chemistry company, develops and produces specialty chemicals using renewable feedstocks. It offers flavor, fragrance, cosmetics, and petrochemical fragrance ingredients. The company serves flavors and fragrances, household cleaning, industrial and institutional cleaning, personal care and cosmetics, polymers, oilfield, agricultural chemicals, mining, environmental cleanup and remediation, paints and coatings, and food markets. P2 Science, Inc. was incorporated in 2009 and is based in Woodbridge, Connecticut.

Sustainable Real Estate Solutions

Venture Round in 2010
Sustainable Real Estate Solutions, Inc. provides on-demand energy and sustainability performance assessment and management software solutions for the commercial real estate industry. The company offers Sustainable Real Estate Manager platform, an Internet-based software as a service, which is used for monitoring building energy and water consumption and cost; automating key performance indicator analytics and reporting; tracking CO2 emissions performance; benchmarking internal and external peer buildings; comparing actual and budgeted performance; identifying no-cost/low-cost energy, water, and waste cost savings opportunities; monetizing hidden carbon assets; and facilitating compliance with energy and sustainability related disclosure, labeling, auditing, and construction regulations. Its platform enables building owners, operators, investors, lenders, tenants, and consultants to assess, benchmark, and optimize the energy and sustainability performance of individual properties and portfolios in the United States and internationally. The company is based in Monroe, Connecticut.

LiveClips

Venture Round in 2012
LiveClips is an innovator and leader in the development and delivery of video content from live sporting events to any Internet-enabled device. LiveClips is a game-changer. Its advanced technology automates the previously time- and labor-intensive processes of creating game clips and highlights, enabling broadcasters and rights holders to dramatically increase the efficiency of their sports coverage. LiveClips is also pioneering a new era of mobile engagement by creating instant in-game clips that users can filter by team, player and kind of play.